Search research articles

Search research articles

Related Experiment Videos

[Is drug advertising reliable?]

¹Avdeling for legemidler, Regionsykehuset i Trondheim.

Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke

|January 23, 1999

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Neonatal withdrawal syndrome following in utero exposure to antidepressants: a disproportionality analysis of VigiBase, the WHO spontaneous reporting database.

Psychological medicine·2022

Same author

Tools for optimising pharmacotherapy in psychiatry (therapeutic drug monitoring, molecular brain imaging and pharmacogenetic tests): focus on antidepressants.

The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry·2021

Same author

Vascular risk factor control and adherence to secondary preventive medication after ischaemic stroke.

Journal of internal medicine·2020

Same author

Topical moistening of mastectomy wounds with diluted tranexamic acid to reduce bleeding: randomized clinical trial.

BJS open·2020

Same author

Cytotoxicity and effect on wound re-epithelialization after topical administration of tranexamic acid.

BJS open·2019

Same author

Language impairment in children aged 5 and 8 years after antiepileptic drug exposure in utero - the Norwegian Mother and Child Cohort Study.

European journal of neurology·2019

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Pharmaceutical advertising for selective serotonin re-uptake inhibitors in Norway often contained inaccurate statements and presented an overly positive drug profile. Many citations were difficult to verify, raising concerns about regulatory compliance.

Area of Science:

Pharmacology
Medical Ethics
Health Communication

Background:

Pharmaceutical advertising plays a crucial role in disseminating information about medications to healthcare professionals.
Ensuring the accuracy and compliance of drug advertisements with regulatory standards is essential for informed prescribing practices.
Selective serotonin re-uptake inhibitors (SSRIs) are widely prescribed, making their advertising quality a significant public health concern.

Purpose of the Study:

To evaluate the quality and regulatory compliance of pharmaceutical advertisements for SSRIs in Norway.
To assess the accuracy of reference citations and adherence to Norwegian drug advertisement regulations.

Main Methods:

A review of 18 advertisements for SSRIs published in two Norwegian medical journals between 1995 and 1997.

Related Experiment Videos

Analysis of 38 reference citations for accuracy and verifiability.

Assessment of 56 statements against Norwegian drug advertisement regulations.

Main Results:

Six citations (16%) contained errors, hindering source identification.
18 statements (33%) had debatable compliance with regulations.
A significant proportion of statements were found to be inaccurate or overly positive.

Conclusions:

The quality of pharmaceutical advertising for SSRIs in Norway during 1995-97 was suboptimal.
Advertisements frequently presented an inaccurate and overly favorable view of drug properties.
There is a need for stricter enforcement of regulations governing pharmaceutical advertising to ensure accuracy and compliance.